CONTACT: Frank Fortin
202.223.7189; ffortin@aphanet.org

WASHINGTON, DC – The American Pharmacists Association (APhA) commends President Biden for signing the Executive Order on America’s Supply Chains to establish more resilient and secure supply chains for critical and essential goods, including pharmaceuticals. 

APhA supports the administration’s efforts to protect our nation’s drug supply and mitigate shortages of both finished drug products and active pharmaceutical ingredients (APIs). Ensuring an adequate drug supply during the COVID-19 public health emergency and beyond will enable pharmacists to continue caring for their patients without disruption.

In January 2021, APhA joined with our partners in the Pharmaceutical Supply and Payment Chain Coalition to urge the Administration to promote resiliency and diversity of the global pharmaceutical supply chain. In addition to the announced 100-day review of the global API supply chain, APhA supports the year-long review of the supply chains for the public health and biological preparedness industrial base, including critical personal protective equipment.

APhA welcomes this executive order as an important step in determining the best ways to ensure the security and resiliency of the pharmaceutical and medical supply chains, and stands ready to assist the administration in this important initiative.